Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Curifylabs Oy |
| Country | Finland |
| Start Date | Sep 01, 2023 |
| End Date | Aug 31, 2025 |
| Duration | 730 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190157849 |
Uniform drug treatments are not always the best option for treating some patient populations including children and the elderly.
The industry now has extensive knowledge on the benefits of personalized medicines that take the age, metabolic and genetic differences of patients into account. However, until now there has not been a practical manufacturing solution to put this knowledge into wide-scale use.
CurifyLabs has created a technology called MiniLab to make high-quality 3D printing of personalized medicines available on site in the pharmacies and bring industry level standards to mass customisation of medicines.
In this project we will finalize a standard process for developing 3D printing compatible formulations and quality control solutions. This will make MiniLab highly scalable across different therapeutic areas.
Curifylabs Oy
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant